Today

Agents

Chat

Arena

Discover

More

App

Polaryx Therapeutics CMO Lisa Bollinger resigns effective immediately - PLYX News | Rallies

Polaryx Therapeutics CMO Lisa Bollinger resigns effective immediately

PLYX•2026-07-21

Chief medical officer resigns

Polaryx Therapeutics Chief Medical Officer Lisa Bollinger resigned effective immediately on July 19, 2026.
Clinical timelines, regulatory plans, and development strategy are expected to remain unchanged.
A search for a successor is underway, and the existing leadership team will assume her responsibilities in the interim.

Related News

Faraday Future Announces Reverse Stock Split To Preserve Nasdaq Listing And Drive Strategic Breakthroughs In Pursuit Of Long-Term Stockholder Value

FFAI•2026-07-21

AppFolio 10% owner Maurice J. Duca sells 13,500 shares worth $2,451,300

APPF•2026-07-21

Orrstown Q2 EPS USD 1.09

Sources

S

Polaryx Therapeutics CMO Lisa Bollinger resigns effective immediately

Sec

ORRF

•

2026-07-21

KKR names ex-Manulife CEO Roy Gori senior advisor

KKR•2026-07-21

Armstrong World Industries Announces Increase To Share Repurchase Program And Quarterly Dividend

AWI•2026-07-21